Last 12 months
Inside the activity.
1 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2024 Filed Jun 6, 2024 20:32 UTC |
Aulick RodneySVP & President, WSS
|
Exercise / conversionCommon Stock | 21,800 | $49.23 | $1,073,214.00 |
DisclosureSEC source: 0001562180-24-004747 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,087 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 16:29 UTC |
Toussaint Claudia SSVP, CPSO
|
GiftCommon Stock | 4,043 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004640 · primarydocument.xml · nonDerivative · entry 1 Toussaint Claudia S · CIK 0001421560 · SVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,204 F1 · shares: Reflects the transfer of shares of common stock from the reporting person's personal account to the Claudia S. Toussaint Revocable Trust of which the reporting person is trustee. The reporting person and members of her immediate family are the sole beneficiaries of the trust. Read SEC document |
| May 24, 2024 Filed May 28, 2024 20:25 UTC |
Aulick RodneySVP & President, WSS
|
Tax withholdingCommon Stock | 1,609 | $144.25 | $232,098.25 |
DisclosureSEC source: 0001562180-24-004469 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,287 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 24, 2023, under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| May 18, 2024 Filed May 21, 2024 20:18 UTC |
Aulick RodneySVP & President, WSS
|
Tax withholdingCommon Stock | 4,268 | $143.32 | $611,689.76 |
DisclosureSEC source: 0001562180-24-004263 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,896 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of: 1) restricted stock units granted on May 18, 2021 under the Evoqua Water Technologies 2017 Equity Plan (Evoqua Plan) that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023; and 2) performance share units granted on May 18, 2021 under the Evoqua Plan that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| May 16, 2024 Filed May 20, 2024 20:18 UTC |
Tretikov LilaDirector
|
GrantCommon Stock | 1,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004229 · primarydocument.xml · nonDerivative · entry 1 Tretikov Lila · CIK 0001620654 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,380 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2025 Annual Meeting of Shareholders. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| May 16, 2024 Filed May 20, 2024 20:18 UTC |
Peribere Jerome ADirector
|
GrantCommon Stock | 1,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004227 · primarydocument.xml · nonDerivative · entry 1 Peribere Jerome A · CIK 0001484527 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,570 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2025 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| May 16, 2024 Filed May 20, 2024 20:18 UTC |
Yadav UdayDirector
|
GrantCommon Stock | 1,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004230 · primarydocument.xml · nonDerivative · entry 1 Yadav Uday · CIK 0001479938 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,326 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2025 Annual Meeting of Shareholders. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| May 16, 2024 Filed May 20, 2024 20:18 UTC |
Morelli Mark DDirector
|
GrantCommon Stock | 1,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004228 · primarydocument.xml · nonDerivative · entry 1 Morelli Mark D · CIK 0001411290 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,974 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2025 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| May 16, 2024 Filed May 20, 2024 20:18 UTC |
Harker Victoria DDirector
|
GrantCommon Stock | 1,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004226 · primarydocument.xml · nonDerivative · entry 1 Harker Victoria D · CIK 0001350579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,835 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2025 Annual Meeting of Shareholders. Read SEC document |
| May 16, 2024 Filed May 20, 2024 20:17 UTC |
FRIEL ROBERT FDirector
|
GrantCommon Stock | 1,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004225 · primarydocument.xml · nonDerivative · entry 1 FRIEL ROBERT F · CIK 0001224110 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,926 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2025 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| May 16, 2024 Filed May 20, 2024 20:19 UTC |
Glatch LisaDirector
|
GrantCommon Stock | 1,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004231 · primarydocument.xml · nonDerivative · entry 1 Glatch Lisa · CIK 0001339795 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,755 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2025 Annual Meeting of Shareholders. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| May 16, 2024 Filed May 20, 2024 20:17 UTC |
ELLIS EARL RAYDirector
|
GrantCommon Stock | 1,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004224 · primarydocument.xml · nonDerivative · entry 1 ELLIS EARL RAY · CIK 0001835584 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,988 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2025 Annual Meeting of Shareholders. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| May 16, 2024 Filed May 20, 2024 20:17 UTC |
Beliveau-Dunn JeanneDirector
|
GrantCommon Stock | 1,156 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-004221 · primarydocument.xml · nonDerivative · entry 1 Beliveau-Dunn Jeanne · CIK 0001714894 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,454 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2025 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service. Read SEC document |
| March 05, 2024 Filed Mar 5, 2024 22:09 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
SaleCommon Stock | 4,547 | $127.53 | $579,878.91 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 10 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,353 F5 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $127.10 to $127.55. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:01 UTC |
Cerwinka FranzSVP & Pres, AWS & Bus Trnsform
|
GrantStock Options (Right to buy) · Derivative | 5,288 | $127.94 Strike: $127.94 | $676,546.72 |
DisclosureSEC source: 0001562180-24-002289 · primarydocument.xml · derivative · entry 7 Cerwinka Franz · CIK 0001813828 · SVP & Pres, AWS & Bus Trnsform 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,288 Underlying: Common Stock · 5,288 shares Expires 2034-03-01 F7 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:01 UTC |
Cerwinka FranzSVP & Pres, AWS & Bus Trnsform
|
SaleCommon Stock | 1,341 | $127.44 | $170,897.04 |
DisclosureSEC source: 0001562180-24-002289 · primarydocument.xml · nonDerivative · entry 6 Cerwinka Franz · CIK 0001813828 · SVP & Pres, AWS & Bus Trnsform 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,892 F6 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a price of $127.44. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:01 UTC |
Cerwinka FranzSVP & Pres, AWS & Bus Trnsform
|
GrantCommon Stock | 1,563 | $127.94 | $199,970.22 |
DisclosureSEC source: 0001562180-24-002289 · primarydocument.xml · nonDerivative · entry 5 Cerwinka Franz · CIK 0001813828 · SVP & Pres, AWS & Bus Trnsform 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,233 F5 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:01 UTC |
Cerwinka FranzSVP & Pres, AWS & Bus Trnsform
|
Tax withholdingCommon Stock | 730 | $127.94 | $93,396.20 |
DisclosureSEC source: 0001562180-24-002289 · primarydocument.xml · nonDerivative · entry 4 Cerwinka Franz · CIK 0001813828 · SVP & Pres, AWS & Bus Trnsform 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,670 F4 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 (193), March 1, 2022 (246), and March 1, 2023 (291) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:01 UTC |
Cerwinka FranzSVP & Pres, AWS & Bus Trnsform
|
Tax withholdingCommon Stock | 1,509 | $127.94 | $193,061.46 |
DisclosureSEC source: 0001562180-24-002289 · primarydocument.xml · nonDerivative · entry 3 Cerwinka Franz · CIK 0001813828 · SVP & Pres, AWS & Bus Trnsform 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,400 F3 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:01 UTC |
Cerwinka FranzSVP & Pres, AWS & Bus Trnsform
|
GrantCommon Stock | 1,956 | $127.94 | $250,250.64 |
DisclosureSEC source: 0001562180-24-002289 · primarydocument.xml · nonDerivative · entry 2 Cerwinka Franz · CIK 0001813828 · SVP & Pres, AWS & Bus Trnsform 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,909 F2 · shares: Reflects the acquisition of 1,956 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:01 UTC |
Cerwinka FranzSVP & Pres, AWS & Bus Trnsform
|
GrantCommon Stock | 1,203 | $127.94 | $153,911.82 |
DisclosureSEC source: 0001562180-24-002289 · primarydocument.xml · nonDerivative · entry 1 Cerwinka Franz · CIK 0001813828 · SVP & Pres, AWS & Bus Trnsform 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,953 F1 · shares: Reflects the acquisition of 1,203 shares of common stock upon vesting of performance-based restricted stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:05 UTC |
Pine Matthew FrancisDirector · Pres. & CEO
|
GrantStock Options (Right to buy) · Derivative | 42,967 | $127.94 Strike: $127.94 | $5,497,197.98 |
DisclosureSEC source: 0001562180-24-002293 · primarydocument.xml · derivative · entry 6 Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,967 Underlying: Common Stock · 42,967 shares Expires 2034-03-01 F7 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:05 UTC |
Pine Matthew FrancisDirector · Pres. & CEO
|
GrantCommon Stock | 12,701 | $127.94 | $1,624,965.94 |
DisclosureSEC source: 0001562180-24-002293 · primarydocument.xml · nonDerivative · entry 5 Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,523 F6 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:05 UTC |
Pine Matthew FrancisDirector · Pres. & CEO
|
Tax withholdingCommon Stock | 1,456 | $127.94 | $186,280.64 |
DisclosureSEC source: 0001562180-24-002293 · primarydocument.xml · nonDerivative · entry 4 Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,822 F5 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 (353), March 1, 2022 (454), and March 1, 2023 (649) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:05 UTC |
Pine Matthew FrancisDirector · Pres. & CEO
|
Tax withholdingCommon Stock | 2,281 | $127.94 | $291,831.14 |
DisclosureSEC source: 0001562180-24-002293 · primarydocument.xml · nonDerivative · entry 3 Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,278 F4 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:05 UTC |
Pine Matthew FrancisDirector · Pres. & CEO
|
GrantCommon Stock | 2,206 | $127.94 | $282,235.64 |
DisclosureSEC source: 0001562180-24-002293 · primarydocument.xml · nonDerivative · entry 2 Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,559 F3 · shares: Reflects the acquisition of 2,206 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 17:05 UTC |
Pine Matthew FrancisDirector · Pres. & CEO
|
GrantCommon Stock | 3,586 | $127.94 | $458,792.84 |
DisclosureSEC source: 0001562180-24-002293 · primarydocument.xml · nonDerivative · entry 1 Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,353 F1 · shares: Reflects the acquisition of 3,586 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:07 UTC |
Grogan William KSVP & Chief Financial Officer
|
GrantStock Options (Right to buy) · Derivative | 13,221 | $127.94 Strike: $127.94 | $1,691,494.74 |
DisclosureSEC source: 0001562180-24-002296 · primarydocument.xml · derivative · entry 2 Grogan William K · CIK 0001694002 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,221 Underlying: Common Stock · 13,221 shares Expires 2034-03-01 F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:07 UTC |
Grogan William KSVP & Chief Financial Officer
|
GrantCommon Stock | 3,908 | $127.94 | $499,989.52 |
DisclosureSEC source: 0001562180-24-002296 · primarydocument.xml · nonDerivative · entry 1 Grogan William K · CIK 0001694002 · SVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,710 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:59 UTC |
Toussaint Claudia SSVP, CPSO
|
GrantStock Options (Right to buy) · Derivative | 5,949 | $127.94 Strike: $127.94 | $761,115.06 |
DisclosureSEC source: 0001562180-24-002286 · primarydocument.xml · derivative · entry 7 Toussaint Claudia S · CIK 0001421560 · SVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,949 Underlying: Common Stock · 5,949 shares Expires 2034-03-01 F6 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:59 UTC |
Toussaint Claudia SSVP, CPSO
|
GrantCommon Stock | 1,759 | $127.94 | $225,046.46 |
DisclosureSEC source: 0001562180-24-002286 · primarydocument.xml · nonDerivative · entry 5 Toussaint Claudia S · CIK 0001421560 · SVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,247 F5 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:59 UTC |
Toussaint Claudia SSVP, CPSO
|
Tax withholdingCommon Stock | 1,055 | $127.94 | $134,976.70 |
DisclosureSEC source: 0001562180-24-002286 · primarydocument.xml · nonDerivative · entry 4 Toussaint Claudia S · CIK 0001421560 · SVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,488 F4 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 (318), March 1, 2022 (416), and March 1, 2023 (321) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:59 UTC |
Toussaint Claudia SSVP, CPSO
|
Tax withholdingCommon Stock | 2,077 | $127.94 | $265,731.38 |
DisclosureSEC source: 0001562180-24-002286 · primarydocument.xml · nonDerivative · entry 3 Toussaint Claudia S · CIK 0001421560 · SVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,543 F3 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:59 UTC |
Toussaint Claudia SSVP, CPSO
|
GrantCommon Stock | 1,805 | $127.94 | $230,931.70 |
DisclosureSEC source: 0001562180-24-002286 · primarydocument.xml · nonDerivative · entry 2 Toussaint Claudia S · CIK 0001421560 · SVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,620 F2 · shares: Reflects the acquisition of 1,805 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 16:59 UTC |
Toussaint Claudia SSVP, CPSO
|
GrantCommon Stock | 2,934 | $127.94 | $375,375.96 |
DisclosureSEC source: 0001562180-24-002286 · primarydocument.xml · nonDerivative · entry 1 Toussaint Claudia S · CIK 0001421560 · SVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,815 F1 · shares: Reflects the acquisition of 2,934 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
GrantStock Options (Right to buy) · Derivative | 7,932 | $127.94 Strike: $127.94 | $1,014,820.08 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · derivative · entry 14 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,932 Underlying: Common Stock · 7,932 shares Expires 2034-03-01 F9 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 5,035 | $0.00 Strike: $86.76 | $0.00 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · derivative · entry 13 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,036 Underlying: Common Stock · 5,035 shares Expires 2032-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The March 1, 2022 option grant vested 5,035 options on March 1, 2023, 5,035 options on March 1, 2024, and will vest 5,036 options on March 1, 2025. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 4,875 | $0.00 Strike: $101.09 | $0.00 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · derivative · entry 12 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,750 Underlying: Common Stock · 4,875 shares Expires 2033-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The March 1, 2023 option grant vested 4,875 options on March 1, 2024, and will vest 4,875 options on March 1, 2025, and 4,875 options on March 1, 2026. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 9,698 | $0.00 Strike: $102.23 | $0.00 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · derivative · entry 11 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,698 shares Expires 2031-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The March 1, 2021 option grant vested 3,201 options on March 1, 2022, 3,265 options on March 1,2023, and 3,232 options on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
SaleCommon Stock | 4,875 | $127.17 | $619,953.75 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 9 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,900 F4 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $127.03 to $127.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
Exercise / conversionCommon Stock | 4,875 | $101.09 | $492,813.75 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 8 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
SaleCommon Stock | 4,870 | $127.14 | $619,171.80 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 7 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,900 F4 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $127.03 to $127.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
SaleCommon Stock | 5,035 | $127.14 | $640,149.90 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 6 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,770 F4 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $127.03 to $127.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
Exercise / conversionCommon Stock | 5,035 | $86.76 | $436,836.60 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 5 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
SaleCommon Stock | 9,698 | $127.14 | $1,233,003.72 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 4 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,770 F4 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). These Shares were executed at a range of prices from $127.03 to $127.30. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
Exercise / conversionCommon Stock | 9,698 | $102.23 | $991,426.54 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 3 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
Tax withholdingCommon Stock | 428 | $127.94 | $54,758.32 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 2 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,770 F3 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2021 (252) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2021 (39), March 1, 2022 (62), and March 1, 2023 (75) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:09 UTC |
Yarkadas HayatiSVP & President, EU, WI & GLS
|
GrantCommon Stock | 7,084 | $127.94 | $906,326.96 |
DisclosureSEC source: 0001562180-24-002298 · primarydocument.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · SVP & President, EU, WI & GLS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,198 F1 · shares: Reflects the acquisition of 4,739 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ROIC (2,934) and Total Shareholder Return (1,805). Reflects an award of 2,345 restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016) that are scheduled to vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:06 UTC |
Aulick RodneySVP & President, WSS
|
GrantStock Options (Right to buy) · Derivative | 5,619 | $127.94 Strike: $127.94 | $718,894.86 |
DisclosureSEC source: 0001562180-24-002295 · primarydocument.xml · derivative · entry 2 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,619 Underlying: Common Stock · 5,619 shares Expires 2034-03-01 F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2025, March 1, 2026 and March 1, 2027. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:06 UTC |
Aulick RodneySVP & President, WSS
|
GrantCommon Stock | 1,661 | $127.94 | $212,508.34 |
DisclosureSEC source: 0001562180-24-002295 · primarydocument.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · SVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,156 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2025, March 1, 2026 and March 1, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.